Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference


Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today that management will present at and participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16th and 17th in Toronto.

Mr. Frank Gleeson, Co-founder and CEO of Satellos, will provide a corporate presentation on Tuesday, April 16, 2024, at 11:30 a.m. ET and will participate in one-on-one meetings during the conference along with the management team of Satellos. The presentation will be available via live webcast on the Events and Presentations page in the Investors section of the Company's website and a replay will be available following the presentation.

About Satellos Bioscience Inc.

Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. Satellos has incorporated breakthrough research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenXTM, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, Satellos is building a pipeline of novel therapeutics to correct muscle stem cell polarity and promote the body's innate muscle repair and regeneration process. The Company's lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. Satellos is headquartered in Toronto, Ontario. For more information, visit www.satellos.com.


These press releases may also interest you

at 17:45
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

at 17:44
Non-cash impairment of SEK 11.4 billion to be recorded in the second quarter 2024, relating to the impairment of intangibles mainly attributed to the Vonage acquisitionReflects lower anticipated market growth in some of Vonage's current portfolioThe...

at 17:40
Bayen Group, a leading provider of IT solutions and services, has been nominated for the prestigious Southern California Minority Supplier Development Council (SCMSDC) Supplier of the Year award by Northrop Grumman, a global aerospace and defense...

at 17:25
The global secondary tickets market size is estimated to grow by USD 132.1 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 34.25% during the forecast period. Rising popularity of sports events is driving...

at 17:25
The global electric car rental market size is estimated to grow by USD 18.00 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.68% during the forecast period. Increasing demand for rental cars due...

at 17:20
The global supercomputer market size is estimated to grow by USD 33.45 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 28.54% during the forecast period. Commercial customers increasingly adopting...



News published on and distributed by: